Investing.com -- Shares of CARGO Therapeutics , Inc. (NASDAQ: CRGX) plummeted 75% following the company's decision to discontinue its Phase 2 clinical trial for firicabtagene autoleucel, citing ...

Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...

Precigen has a market cap of $468mn and a cash runway into 2026, but needs more funds for commercialization. Check out my ...

Topline data from FIBRONEER-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in forced vital capacity [mL] at week 52 vers ...

All three were hooked up to machines that provided a readout of their vital signs, and all three were prepared to have a ...

A biotech company is attempting to persuade Kansas legislators to modify the state’s controlled substances act in advance of ...

OLIPOP, Oakland, Calif., announced the successful closing of its Series C funding round, anchored by a $50 million investment ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

The Clinical Trials Market report delivers crucial insights into the ... this report acts as a strategic tool for organizations striving to meet their business goals. Phase I studies usually test new ...

accounted for 18% of the total sample size in the Phase 2 study. A consistent top-enroller in acute schizophrenia clinical trials, Segal Trials contributed to the study sample size with a rate of ...

The UK experienced a notable increase in advanced therapy clinical trials in 2024, reaching 187 ongoing trials. This marks a 7% rise from the previous year. Particularly, phase I trials saw an ...